Theranostic Advances in Breast Cancer in Nuclear Medicine

被引：52
|
作者：
Vahidfar, Nasim [1 ]
Aghanejad, Ayuob [2 ]
Ahmadzadehfar, Hojjat [3 ]
Farzanehfar, Saeed [1 ]
Eppard, Elisabeth [4 ,5 ]
机构：
[1] Univ Tehran Med Sci, Vali Asr Hosp, Dept Nucl Med, Tehran 1419733141, Iran
[2] Tabriz Univ Med Sci, Biomed Inst, Res Ctr Pharmaceut Nanotechnol, Tabriz 51368, Iran
[3] Klinikum Westfalen, Dept Nucl Med, D-44149 Dortmund, Germany
[4] Positronpharma SA, Rancagua 878, Santiago 7500621, Chile
[5] Univ Hosp Magdeburg, Dept Nucl Med, Leipziger Str 44, D-39120 Magdedurg, Germany
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 09期
关键词：
theranostic; radiopharmaceutical; imaging; therapy; GASTRIN-RELEASING-PEPTIDE; NEUROENDOCRINE TUMORS; BOMBESIN RECEPTORS; PET; EXPRESSION; DIAGNOSIS; SUBTYPES; FIBROBLASTS; LIGANDS; PATIENT;
D O I：
10.3390/ijms22094597
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The implication of 'theranostic' refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.
引用
收藏
页数：17
相关论文
共 50 条
  • [41] PYTA: a universal chelator for advancing the theranostic palette of nuclear medicine
    Simms, Megan E.
    Li, Zhiyao
    Sibley, Megan M.
    Ivanov, Alexander S.
    Lara, Caroline M.
    Johnstone, Timothy C.
    Kertesz, Vilmos
    Fears, Amanda
    White, Frankie D.
    Thorek, Daniel L. J.
    Thiele, Nikki A.
    CHEMICAL SCIENCE, 2024, 15 (29) : 11279 - 11286
  • [42] Theranostic approaches in nuclear medicine: current status and future prospects
    Filippi, Luca
    Chiaravalloti, Agostino
    Schillaci, Orazio
    Cianni, Roberto
    Bagni, Oreste
    EXPERT REVIEW OF MEDICAL DEVICES, 2020, 17 (04) : 331 - 343
  • [43] Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs
    Czernin, Johannes
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (08) : 1037 - 1037
  • [44] Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine
    Urbain, Jean-Luc
    Scott, Andrew M.
    Lee, Sze Ting
    Buscombe, John
    Weston, Charlotte
    Hatazawa, Jun
    Kinuya, Seigo
    Singh, Baljinder
    Haidar, Mohamad
    Ross, Andrew
    Lamoureux, Francois
    Kunikowska, Jolanta
    Wadsak, Wolfgang
    Dierckx, Rudi
    Paez, Diana
    Giammarile, Francesco
    Lee, Kyung-Han
    Hyun, O. Joo
    Moshe, Modiselle
    Louw, Lizette
    More, Stuart
    Nadel, Helen
    Lee, Daniel
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 986 - 991
  • [45] Skeletal metastases from breast cancer: Imaging with nuclear medicine
    Cook, GJR
    Fogelman, I
    SEMINARS IN NUCLEAR MEDICINE, 1999, 29 (01) : 69 - 79
  • [46] Restaging Infiltrating Lobular Breast Cancer Patients With Nuclear Medicine
    Grigolato, D.
    Pellini, F.
    Invento, A.
    Filippi, E.
    Cucca, M.
    Locantore, L.
    Zuffante, M.
    Pollini, G. P.
    Ferdeghini, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S666 - S667
  • [47] ONCOLOGY "Metastatic breast cancer, issues and perspectives for nuclear medicine"
    Ouvrard, E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (5-6): : 399 - 400
  • [48] Advances in the Molecular Analysis of Breast Cancer: Pathway Toward Personalized Medicine
    Rosa, Marilin
    CANCER CONTROL, 2015, 22 (02) : 211 - 219
  • [49] Career lifetime advances in nuclear medicine
    Hilson, Andrew
    CLINICAL MEDICINE, 2011, 11 (05) : 470 - 472
  • [50] ADVANCES IN NUCLEAR-MEDICINE IN CHINA
    ZHOU, Q
    CHINESE MEDICAL JOURNAL, 1990, 103 (01) : 80 - 83
12345